DJIA 15,112.19 -206.04 -1.35%
NASDAQ 3,443.20 -38.98 -1.12%
S&P 500 1,628.93 -22.88 -1.39%
market minute promo

Amarin Corp plc (ADR)

NASDAQ: AMRN

+ Add to Portfolio

company name or ticker

Is ANCHOR Do Or Die For Amarin?

6/19/2013 by Seeking Alpha

Amarin: FDA Panel Date, Misplaced Hype For Fixed-Dose Combo

6/19/2013 by TheStreet

Amarin: Mr. NCE Guy Has Left The Building

6/16/2013 by Seeking Alpha

AstraZeneca's Buying Spree Bolsters Pipeline

A string of recent acquisitions means AstraZeneca is taking a proactive approach to giving its pipeline life.
6/14/2013 by DailyFinance

Amarin Investors Should Avoid The Bullish Speculation

6/12/2013 by Seeking Alpha

Bull, Bear, Or Indifferent: Profiting From Amarin's Latest

6/11/2013 by Seeking Alpha

Amarin Investors Should Avoid The Bear Traps

6/10/2013 by Seeking Alpha

Why You Should Care About This Diabetes Drug Saga

Are changes to Glaxo's Avandia a sign that the FDA is lightening up?
6/8/2013 by DailyFinance

As If Amarin Needs Another Worry, Here Comes A Vascepa FDA Panel

6/6/2013 by TheStreet

June 14th Options Now Available For Amarin Corp Plc (AMRN)

6/6/2013 by TheStreet
See More Articles...